TY - JOUR
T1 - Advanced gastric cancer in an elderly woman showing histopathologic CR after a course of S-1 and CDDP combination therapy
AU - Kadokawa, Yoshio
AU - Sonoda, Kentaro
AU - Nakajima, Sanae
AU - Kawabe, Atsushi
AU - Egawa, Hiroto
PY - 2010/4/6
Y1 - 2010/4/6
N2 - An 80-year-old woman was diagnosed with advanced gastric cancer of T2N0H0P0M0, Stage I B. She was strongly advised to undergo surgery, but refused this option. Because the performance status (PS) was 1, combination chemotherapy with S-1 100 mg/day (day 1-21) and CDDP 50mg/m2 (day 8) was initiated. After one course of treatment was completed, she changed her mind and expressed the wish to undergo an operation for her disease, which led to proximal gastrectomy (double tract reconstruction) being performed. A histopathological examination revealed CR of the disease with no cancer cells. As the population grows older, the number of elderly patients with advanced gastric cancer will increase in the future. Therefore, S-1 and CDDP combination therapy may be a treatment of choice for gastric cancer with dose reduction according to patient status, if the elderly patient refuses a curative operation. It may well prove to be an effective treatment in the elderly provided the dosage and administration are appropriate.
AB - An 80-year-old woman was diagnosed with advanced gastric cancer of T2N0H0P0M0, Stage I B. She was strongly advised to undergo surgery, but refused this option. Because the performance status (PS) was 1, combination chemotherapy with S-1 100 mg/day (day 1-21) and CDDP 50mg/m2 (day 8) was initiated. After one course of treatment was completed, she changed her mind and expressed the wish to undergo an operation for her disease, which led to proximal gastrectomy (double tract reconstruction) being performed. A histopathological examination revealed CR of the disease with no cancer cells. As the population grows older, the number of elderly patients with advanced gastric cancer will increase in the future. Therefore, S-1 and CDDP combination therapy may be a treatment of choice for gastric cancer with dose reduction according to patient status, if the elderly patient refuses a curative operation. It may well prove to be an effective treatment in the elderly provided the dosage and administration are appropriate.
UR - http://www.scopus.com/inward/record.url?scp=79960798402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960798402&partnerID=8YFLogxK
M3 - Article
C2 - 20414032
AN - SCOPUS:79960798402
SN - 0385-0684
VL - 37
SP - 711
EP - 713
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 4
ER -
